This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jun;23(6):555-8.

doi: 10.1097/01.inf.0000130155.42392.04.

Heterologous immunity and the nonspecific effects of vaccines: a major medical advance?

Affiliations

PMID: 15194839
DOI: 10.1097/01.inf.0000130155.42392.04

Review

Heterologous immunity and the nonspecific effects of vaccines: a major medical advance?

Frank Shann. Pediatr Infect Dis J. 2004 Jun.

. 2004 Jun;23(6):555-8.

doi: 10.1097/01.inf.0000130155.42392.04.

Author

Affiliation

¹ Royal Children's Hospital, Melbourne, Australia.

PMID: 15194839
DOI: 10.1097/01.inf.0000130155.42392.04

Erratum in

Pediatr Infect Dis J. 2004 Aug;23(8):778

No abstract available

PubMed Disclaimer

Similar articles

Disruptions in the supply of routinely recommended childhood vaccines in the United States.
Santoli JM, Klein JO, Peter G, Orenstein WA. Santoli JM, et al. Pediatr Infect Dis J. 2004 Jun;23(6):553-4. doi: 10.1097/00006454-200406000-00014. Pediatr Infect Dis J. 2004. PMID: 15194838 Review. No abstract available.
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R, Kuriyakose S, Mesaros N, Han HH, Tomlinson R, Faust SN, Snape MD, Pollard AJ, Finn A. Marlow R, et al. Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22. Vaccine. 2018. PMID: 29576304 Clinical Trial.
Non-specific effects of childhood vaccines.
Yung CF. Yung CF. BMJ. 2016 Oct 13;355:i5434. doi: 10.1136/bmj.i5434. BMJ. 2016. PMID: 27737824 Free PMC article.
Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H. Paulke-Korinek M, et al. Vaccine. 2011 Jul 18;29(32):5130-6. doi: 10.1016/j.vaccine.2011.05.046. Epub 2011 May 30. Vaccine. 2011. PMID: 21624412
Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
West DJ, Rabalais GP, Watson B, Keyserling HL, Matthews H, Hesley TM. West DJ, et al. BioDrugs. 2001;15(6):413-8. doi: 10.2165/00063030-200115060-00007. BioDrugs. 2001. PMID: 11520252 Review.

See all similar articles

Cited by

Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.
Aaby P, Martins CL, Garly ML, Andersen A, Fisker AB, Claesson MH, Ravn H, Rodrigues A, Whittle HC, Benn CS. Aaby P, et al. Clin Infect Dis. 2014 Aug 15;59(4):484-92. doi: 10.1093/cid/ciu354. Epub 2014 May 14. Clin Infect Dis. 2014. PMID: 24829213 Free PMC article. Clinical Trial.
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.
Aaby P, Martins CL, Garly ML, Balé C, Andersen A, Rodrigues A, Ravn H, Lisse IM, Benn CS, Whittle HC. Aaby P, et al. BMJ. 2010 Nov 30;341:c6495. doi: 10.1136/bmj.c6495. BMJ. 2010. PMID: 21118875 Free PMC article. Clinical Trial.
Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
Page KR, Jedlicka AE, Fakheri B, Noland GS, Kesavan AK, Scott AL, Kumar N, Manabe YC. Page KR, et al. Infect Immun. 2005 Dec;73(12):8369-80. doi: 10.1128/IAI.73.12.8369-8380.2005. Infect Immun. 2005. PMID: 16299335 Free PMC article.
Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau.
Jensen ML, Dave S, Schim van der Loeff M, da Costa C, Vincent T, Leligdowicz A, Benn CS, Roth A, Ravn H, Lisse IM, Whittle H, Aaby P. Jensen ML, et al. PLoS One. 2006 Dec 20;1(1):e101. doi: 10.1371/journal.pone.0000101. PLoS One. 2006. PMID: 17183634 Free PMC article.
Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
Shann F. Shann F. BMJ. 2005 Apr 9;330(7495):844; author reply 844. doi: 10.1136/bmj.330.7495.844. BMJ. 2005. PMID: 15817557 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer